JP2025159730A5 - - Google Patents

Info

Publication number
JP2025159730A5
JP2025159730A5 JP2025114462A JP2025114462A JP2025159730A5 JP 2025159730 A5 JP2025159730 A5 JP 2025159730A5 JP 2025114462 A JP2025114462 A JP 2025114462A JP 2025114462 A JP2025114462 A JP 2025114462A JP 2025159730 A5 JP2025159730 A5 JP 2025159730A5
Authority
JP
Japan
Prior art keywords
seq
nucleotide sequence
nucleic acid
canine
set forth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025114462A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025159730A (ja
Filing date
Publication date
Priority claimed from PCT/EP2020/069923 external-priority patent/WO2021009187A1/en
Application filed filed Critical
Publication of JP2025159730A publication Critical patent/JP2025159730A/ja
Publication of JP2025159730A5 publication Critical patent/JP2025159730A5/ja
Pending legal-status Critical Current

Links

JP2025114462A 2019-07-15 2025-07-07 イヌctla-4に対するイヌ化抗体 Pending JP2025159730A (ja)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US201962874287P 2019-07-15 2019-07-15
US62/874,287 2019-07-15
US201962926047P 2019-10-25 2019-10-25
US62/926,047 2019-10-25
US202063048873P 2020-07-07 2020-07-07
US63/048,873 2020-07-07
PCT/EP2020/069923 WO2021009187A1 (en) 2019-07-15 2020-07-15 Caninized antibodies against canine ctla-4
JP2022502248A JP7757271B2 (ja) 2019-07-15 2020-07-15 イヌctla-4に対するイヌ化抗体

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2022502248A Division JP7757271B2 (ja) 2019-07-15 2020-07-15 イヌctla-4に対するイヌ化抗体

Publications (2)

Publication Number Publication Date
JP2025159730A JP2025159730A (ja) 2025-10-21
JP2025159730A5 true JP2025159730A5 (https=) 2025-12-04

Family

ID=71620454

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022502248A Active JP7757271B2 (ja) 2019-07-15 2020-07-15 イヌctla-4に対するイヌ化抗体
JP2025114462A Pending JP2025159730A (ja) 2019-07-15 2025-07-07 イヌctla-4に対するイヌ化抗体

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2022502248A Active JP7757271B2 (ja) 2019-07-15 2020-07-15 イヌctla-4に対するイヌ化抗体

Country Status (8)

Country Link
US (1) US12435143B2 (https=)
EP (1) EP3999538A1 (https=)
JP (2) JP7757271B2 (https=)
CN (2) CN114174337B (https=)
AU (1) AU2020312686A1 (https=)
BR (1) BR112022000721A2 (https=)
CA (1) CA3145345A1 (https=)
WO (1) WO2021009187A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3216131A1 (en) * 2021-04-21 2022-10-27 Nicola J. MASON Canine monoclonal antibodies against canine cytotoxic t lymphocyte associated protein 4 (ctla-4)
US12263232B1 (en) * 2024-06-10 2025-04-01 Wyvern Pharmaceuticals Inc. Composition for regulating production of proteins

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4447233A (en) 1981-04-10 1984-05-08 Parker-Hannifin Corporation Medication infusion pump
US4439196A (en) 1982-03-18 1984-03-27 Merck & Co., Inc. Osmotic drug delivery system
US4447224A (en) 1982-09-20 1984-05-08 Infusaid Corporation Variable flow implantable infusion apparatus
US4487603A (en) 1982-11-26 1984-12-11 Cordis Corporation Implantable microinfusion pump system
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4596556A (en) 1985-03-25 1986-06-24 Bioject, Inc. Hypodermic injection apparatus
EP0216846B2 (en) 1985-04-01 1995-04-26 Celltech Limited Transformed myeloma cell-line and a process for the expression of a gene coding for a eukaryotic polypeptide employing same
GB8601597D0 (en) 1986-01-23 1986-02-26 Wilson R H Nucleotide sequences
US5260203A (en) 1986-09-02 1993-11-09 Enzon, Inc. Single polypeptide chain binding molecules
EP0281604B1 (en) 1986-09-02 1993-03-31 Enzon Labs Inc. Single polypeptide chain binding molecules
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US4790824A (en) 1987-06-19 1988-12-13 Bioject, Inc. Non-invasive hypodermic injection device
US4941880A (en) 1987-06-19 1990-07-17 Bioject, Inc. Pre-filled ampule and non-invasive hypodermic injection device assembly
GB8717430D0 (en) 1987-07-23 1987-08-26 Celltech Ltd Recombinant dna product
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
US5064413A (en) 1989-11-09 1991-11-12 Bioject, Inc. Needleless hypodermic injection device
US5312335A (en) 1989-11-09 1994-05-17 Bioject Inc. Needleless hypodermic injection device
ATE207080T1 (de) 1991-11-25 2001-11-15 Enzon Inc Multivalente antigen-bindende proteine
US5383851A (en) 1992-07-24 1995-01-24 Bioject Inc. Needleless hypodermic injection device
US6005079A (en) 1992-08-21 1999-12-21 Vrije Universiteit Brussels Immunoglobulins devoid of light chains
DK1621554T4 (da) 1992-08-21 2012-12-17 Univ Bruxelles Immunoglobuliner blottet for lette kæder
ES2162863T3 (es) 1993-04-29 2002-01-16 Unilever Nv Produccion de anticuerpos o fragmentos (funcionalizados) de los mismos derivados de inmunoglobulinas de cadena pesada de camelidae.
GB9818110D0 (en) 1998-08-19 1998-10-14 Weston Medical Ltd Needleless injectors and other devices
US6096002A (en) 1998-11-18 2000-08-01 Bioject, Inc. NGAS powered self-resetting needle-less hypodermic jet injection apparatus and method
CZ302706B6 (cs) 1998-12-23 2011-09-14 Pfizer Inc. Lidská monoklonální protilátka, farmaceutická kompozice tuto protilátku obsahující, bunecná linie produkující tuto protilátku, izolovaná molekula kódující težký nebo lehký retezec uvedené protilátky, hostitelská bunka obsahující tuto izolovanou molek
CA2704600C (en) 1999-04-09 2016-10-25 Kyowa Kirin Co., Ltd. A method for producing antibodies with increased adcc activity
US7605238B2 (en) 1999-08-24 2009-10-20 Medarex, Inc. Human CTLA-4 antibodies and their uses
US6946292B2 (en) 2000-10-06 2005-09-20 Kyowa Hakko Kogyo Co., Ltd. Cells producing antibody compositions with increased antibody dependent cytotoxic activity
US7261890B2 (en) 2001-12-21 2007-08-28 Idexx Laboratories, Inc. Methods for using canine immunoglobulin variable domains and caninized antibodies
GB0903325D0 (en) 2009-02-26 2009-04-08 Univ Aberdeen Antibody molecules
GB201103955D0 (en) 2011-03-09 2011-04-20 Antitope Ltd Antibodies
GB201114858D0 (en) 2011-08-29 2011-10-12 Nvip Pty Ltd Anti-nerve growth factor antibodies and methods of using the same
CN106029697B (zh) 2013-12-20 2021-06-04 英特维特国际股份有限公司 具有经修饰的ch2-ch3序列的犬抗体
CN107074952B (zh) * 2014-09-30 2021-04-09 英特维特国际股份有限公司 结合犬pd-l1的pd-l1抗体
US10106107B2 (en) 2014-11-13 2018-10-23 Mitsubishi Electric Corporation Waterproof type control unit and waterproof type control unit manufacturing method
WO2016183469A1 (en) * 2015-05-13 2016-11-17 Robert Kirken Anti-ctla-4 blockade
WO2017062615A2 (en) 2015-10-08 2017-04-13 Macrogenics, Inc. Combination therapy for the treatment of cancer
CA3005696A1 (en) 2015-12-18 2017-06-22 Intervet International B.V. Caninized human antibodies to human and canine il-4r alpha

Similar Documents

Publication Publication Date Title
JP2025159730A5 (https=)
US7186524B2 (en) Method for exposing peptides and polypeptides on the cell surface of bacteria
JP2005516613A5 (https=)
CN101652379B (zh) 用于增加宿主细胞中重组蛋白表达的重组表达载体元件(reves)
JPH0838176A (ja) 改良組換dna分子
WO2017035241A1 (en) Enhanced production of immunoglobulins
RU2018119366A (ru) Мыши с гуманизированной легкой цепью
EP0135532A1 (en) PROCESS FOR THE PRODUCTION AND SELECTIVE ISOLATION OF PROTEINS AND POLYPEPTIDES, THEIR EXPRESSION AND RECOMBINANT VECTOR AND FUSION PROTEINS THAT MAY FIX ON THE CONSTANT REGION OF IMMUNOGLOBULINS.
US20200109197A1 (en) Recombinant antibody compositions and methods of use thereof
JP2021524275A5 (https=)
SE452632B (sv) Rekombinantplasmidvektor samt forfarande for framstellning av proteiner medelst dna-teknik varvid anvendes bl a regleringsdelen av genen for bacillus amyloliquefaciens-alfa-amylas
JP2004041218A5 (https=)
JP2025090679A5 (https=)
JP2025081549A5 (https=)
JP2004528803A5 (https=)
CN119490589A (zh) 一种靶向Nectin-4的纳米抗体、嵌合抗原受体CAR及应用
JP4448138B2 (ja) 大腸菌シグナル配列を用いて抗体断片を分泌する発現ベクター及び抗体断片の大量生産方法
JP3219772B2 (ja) アデノ随伴ウイルスcapタンパク質を特異的に認識するモノクローナル抗体
JP2024546759A5 (https=)
CN101988049B (zh) 共表达小鼠膜型白细胞介素15和Rae-1ε的转基因细胞及其制备方法
CN108823208B (zh) 一种四环素诱导启动子及其制备方法和应用
WO2020216191A1 (zh) 制备噬菌体文库的方法
JP2002542825A5 (https=)
CN102676532B (zh) 通过mda-pcr富集基因组重排免疫球蛋白基因及生产抗体的方法
JPH0315388A (ja) msDNAの製造方法